Basic Information
Immunorock is developing an immunotherapy drug for cancer treatment. The company specializes in providing a novel oral vaccine platform technology that utilizes the properties of bifidobacteria. It is currently researching an oral cancer vaccine and a coronavirus prevention vaccine, enabling healthcare providers to treat patients and improve their lives.
Immunorock Co. Ltd.
Tokyo,Tokyo,Japan
15~50 people
April 22, 2021
--
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios